Archives
Royalty Pharma Offers US$6.6Bln Offer for Elan
Royalty Pharma offers US$11 per Elan share. While Elan is in the process of selling its fifty percent share in the successful multiple scelerosis drug Tysabri with its US partner Biogen Idec, here comes American investment firm Royalty Pharma offering US6.
Kuwait's Zain to Sell Iraqi Unit Stake in IPO
Zain, a telecom firm in Kuwait, is in the process of selling its stake in its Iraqi unit. Kuwaiti telecom operator Zain is set to sell its stake in its business unit in Iraq through initial public offering as part of its $1.
Ship Owner Continues Lease Agreement
Capital Product Partners LP agrees to lower bareboat charter costs to lease to Overseas Shipholding.
Kodak Gets Flexible Financing
Kodak gets flexible financing and reorganization plans as it prepares to come out of bankruptcy. The bankrupt photography icon Eastman Kodak Inc was allowed to amend its financing deal in order to become more financially flexible as it girds to exit Chapter 11 bankruptcy protection.




